Document is current
Any future updates will be listed below
-
Authors
Galbo-Thomma, Lindsey K.
Marecki, Courtney
Kim, Caroline M.
Hiranita, Takato
Taylor, Julia R.
Maguire, David R.
Hicks, Dustin
Gebo, Ann
Khaimraj, Aaron
Baehr, Carly
Pravetoni, Marco
France, Charles P. https://orcid.org/0000-0001-5157-6307
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA51658, UG3DA057850, T32DA031115)
Welch Foundation (AQ-0039)
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 21 January 2025
First Online: 5 February 2025
Declarations
:
: The mAb described herein has been disclosed through patent applications (inventors: Pravetoni, Baehr, Hicks). M. Pravetoni is the founder of CounterX Therapeutics, Inc. Other authors have no financial conflicts or competing interests to declare.
